155 related articles for article (PubMed ID: 24152640)
1. Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.
Yang J; Zhen L; Zhuang H
Clin Nucl Med; 2013 Dec; 38(12):988-91. PubMed ID: 24152640
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.
Iagaru A; Goris ML
Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1746. PubMed ID: 18648808
[No Abstract] [Full Text] [Related]
3. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
4. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
5. Earlier detection of bone metastases from pleomorphic liposarcoma in a pediatric patient by FDG PET/CT than planar 99mTc MDP bone scan.
Yang J; Codreanu I; Servaes S; Zhuang H
Clin Nucl Med; 2012 May; 37(5):e104-7. PubMed ID: 22475918
[TBL] [Abstract][Full Text] [Related]
6. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
7. Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
Hong J; Lee JH
Ann Hematol; 2013 Apr; 92(4):565-6. PubMed ID: 23086509
[No Abstract] [Full Text] [Related]
8. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
[TBL] [Abstract][Full Text] [Related]
9. Peripheral bone involvement of intravascular large B-cell lymphoma on 99mTc-MDP bone scan and 18F-FDG PET/CT.
Oh SY; Cheon GJ; Jeong E; Lee S; Park TG; Pahk K; Choe JG
Clin Nucl Med; 2012 Aug; 37(8):810-1. PubMed ID: 22785520
[TBL] [Abstract][Full Text] [Related]
10. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
[TBL] [Abstract][Full Text] [Related]
11. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow metastases in an otherwise operable gall bladder cancer: rare site of distant metastases detected on FDG PET/CT.
Puranik AD; Purandare N; Agrawal A; Shah S; Rangarajan V
Clin Nucl Med; 2014 Feb; 39(2):e169-72. PubMed ID: 23877515
[TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
Eugene T; Corradini N; Carlier T; Dupas B; Leux C; Bodet-Milin C
Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 18 FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis.
Rong J; Wang S; Ding Q; Yun M; Zheng Z; Ye S
Surg Oncol; 2013 Jun; 22(2):86-91. PubMed ID: 23726506
[TBL] [Abstract][Full Text] [Related]
15. Submandibular gland carcinoma with unusual widespread bone marrow metastases detected by Tc-99m MDP bone scan and FDG PET.
Ko HL; Tsang YW; Chen YK; Chi KH
Clin Nucl Med; 2007 Nov; 32(11):866-7. PubMed ID: 18075424
[No Abstract] [Full Text] [Related]
16. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
[TBL] [Abstract][Full Text] [Related]
17. Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
Cheng G
Ann Hematol; 2013 Jan; 92(2):283-4. PubMed ID: 22885991
[No Abstract] [Full Text] [Related]
18. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
[TBL] [Abstract][Full Text] [Related]
19. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
Ricard F; Cimarelli S; Deshayes E; Mognetti T; Thiesse P; Giammarile F
Clin Nucl Med; 2011 Aug; 36(8):672-7. PubMed ID: 21716019
[TBL] [Abstract][Full Text] [Related]
20. Stratified radiotracer activity in a floppy neobladder on both 18F-FDG PET/CT and 99mTc-MDP bone scan.
Yoon HJ; Kim BS
Clin Nucl Med; 2015 Mar; 40(3):224-7. PubMed ID: 25140564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
